Latest On Xencor, Inc (XNCR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-19 17:06 EST | News | Xencor a buy at BofA on protein therapeutics | N/A |  |
| 2023-05-09 05:53 EST | News | Xencor, Inc. (XNCR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 17:08 EST | News | Xencor GAAP EPS of -$1.02 misses by $0.36, revenue of $18.96M misses by $7.93M | N/A | |
| 2023-02-24 10:23 EST | News | Xencor, Inc. (XNCR) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-23 21:21 EST | News | Xencor GAAP EPS of -$0.20 beats by $0.60, revenue of $21.6M beats by $2.36M | N/A | |
| 2023-02-22 19:17 EST | News | Xencor Q4 2022 Earnings Preview | N/A | |
| 2023-02-07 12:17 EST | News | Atreca and Xencor select first bispecific antibody for collaboration | N/A | |
| 2022-11-08 02:51 EST | News | Xencor GAAP EPS of -$0.55 beats by $0.13, revenue of $27.3M beats by $6.25M | N/A | |
| 2022-11-08 02:51 EST | News | Xencor, Inc. (XNCR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-05 03:47 EST | News | Xencor Q3 2022 Earnings Preview | N/A | |
| 2022-08-11 17:59 EST | News | Xencor (XNCR) Investor Presentation - Slideshow | N/A | |
| 2022-08-04 18:59 EST | News | Xencor stock down 7% on Q2 result miss | N/A | |
| 2022-08-04 03:43 EST | News | Xencor GAAP EPS of -$0.57 misses by $0.10, revenue of $30.18M misses by $3.83M | N/A | |
| 2022-08-04 03:43 EST | News | Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2022 Results Earnings Call Transcript | N/A | |
| 2022-08-02 22:53 EST | News | Xencor Q2 2022 Earnings Preview | N/A | |
| 2022-08-02 07:42 EST | News | Xencor signs license agreement for cancer targeting bispecific antibodies | N/A | |
| 2022-06-04 09:50 EST | News | Xencor: Capital-Efficient Platform Tech Play With A Lot Going On | N/A | |
| 2022-05-08 06:00 EST | News | Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 10:59 EST | News | Xencor GAAP EPS of $0.39 beats by $1.03, revenue of $85.5M beats by $59.33M | N/A | |
| 2022-05-05 13:21 EST | News | Xencor Q1 2022 Earnings Preview | N/A | |
| 2022-02-24 04:07 EST | News | Xencor GAAP EPS of $1.21 beats by $1.11, revenue of $154.02M beats by $77.73M | N/A | |
| 2022-02-24 04:07 EST | News | Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 08:07 EST | News | Xencor Q4 2021 Earnings Preview | N/A | |
| 2021-11-22 12:58 EST | News | Zenas Bio acquires worldwide rights to Xencor's obexelimab | N/A | |
| 2021-11-08 21:44 EST | News | Xencor EPS beats by $0.07, beats on revenue | N/A | |
| 2021-11-08 21:43 EST | News | Xencor's (XNCR) CEO Bassil Dahiyat on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-08 01:28 EST | News | Xencor Q3 2021 Earnings Preview | N/A | |
| 2021-10-04 16:06 EST | News | Johnson & Johnson’s Janssen unit teams up with Xencor for cancer candidates | N/A | |
| 2021-09-08 18:35 EST | News | INmune slides 20% following 192.5K share offering from Xencor | N/A | |
| 2021-08-17 03:33 EST | News | Xencor, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-05 16:15 EST | News | Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-04 18:10 EST | News | Xencor EPS beats by $1.48, beats on revenue | N/A | |
| 2021-07-22 09:32 EST | News | Xencor and Bristol Myers Squibb ink technology license agreement | N/A | |
| 2021-07-22 09:28 EST | News | Xencor and Vir to benefit from for FDA authorization for COVID-19 therapy: SVB Leerink | N/A | |
| 2021-05-06 01:55 EST | News | Xencor EPS beats by $0.70, beats on revenue | N/A | |
| 2021-04-29 01:07 EST | News | Xencor doses first subject in early-stage XmAB564 autoimmune disease study | N/A | |
| 2021-04-10 06:45 EST | News | Inmune Bio files to sell 1.7M shares from shareholder Xencor | N/A | |
| 2021-02-25 15:28 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-25 05:21 EST | Analyst Rating | The Analyst Target Price has increased from $51.27 to $54.33. | Buy | |
| 2021-02-24 16:42 EST | News | Xencor Inc (XNCR) CEO Bassil Dahiyat on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-24 05:09 EST | Earnings Estimate | An EPS average of -$0.61 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-24 05:09 EST | Earnings Estimate | An EPS average of -$2.38 is estimated for the 2022 year. | Sell | |
| 2021-02-24 05:09 EST | Analyst Rating | The Analyst Target Price has increased from $51 to $51.27. | Buy | |
| 2021-02-23 23:18 EST | News | Xencor EPS beats by $0.12, beats on revenue | N/A | |
| 2021-01-20 13:30 EST | Analyst Rating | The Analyst Target Price has increased from $50.55 to $51. | Buy | |
| 2021-01-08 01:03 EST | Analyst Rating | The Analyst Target Price has increased from $50.18 to $50.55. | Buy | |
| 2021-01-07 03:49 EST | News | Xencor, MD Anderson ink development pact for CD3 bispecific antibody for cancer | N/A | |
| 2021-01-07 00:58 EST | Analyst Rating | The Analyst Target Price has increased from $49.64 to $50.18. | Buy | |
| 2020-12-07 14:09 EST | News | Xencor inks agreement with Janssen for the potential prostate cancer treatment | N/A | |
| 2020-11-26 22:09 EST | Financials | Company financials have been released. | Neutral | |
About Xencor, Inc (XNCR):
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obexelimab, an immune inhibitor that has completed Phase 2 clinical trial for the treatment of IgG4-related disease and systemic lupus erythematosus, as well as in Phase 1b/2a clinical trial to treat moderate-to-severe rheumatoid arthritis; Plamotamab, a tumor-targeted antibody, which is in Phase 1 clinical trial to treat non-Hodgkin lymphoma; XmAb717, XmAb841, and XmAb104, a bispecific antibody that is in Phase 1 clinical trial to treat patients with selected advanced solid tumors; and Vibecotamab, which is in Phase 1 clinical trial for the treatment of acute myeloid leukemia and other CD123-expressing hematologic malignancies. It is also developing Tidutamab that is in Phase 1 clinical trial to treat neuroendocrine tumors and gastrointestinal stromal tumors; XmAb564 to treat Autoimmune diseases; XmAb819 for the treatment of renal cell carcinoma; and XmAb306/RO7310729, which is in Phase 1 clinical trial to treat solid tumors. In addition, the company provides Monjuvi for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; Ultomiris to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome; and AIMab7195 to reduce blood serum levels of IgE, which mediates allergic responses and allergic disease. It has a collaboration and license agreement with Genentech, MorphoSys AG, Nestlé S.A., Novartis AG, INmune Bio, Inc., Janssen Biotech, Inc., Astellas Pharma, Inc., Amgen Inc., Atreca, Inc., and The University of Texas MD Anderson Cancer Center. Xencor, Inc. was incorporated in 1997 and is headquartered in Monrovia, California.
General
- Name Xencor, Inc
- Symbol XNCR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 202
- Fiscal Year EndDecember
- IPO Date2013-12-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.xencor.com
View More
Valuation
- Trailing PE 67.39
- Price/Sales (Trailing 12 Mt.) 21.93
- Price/Book (Most Recent Quarter) 4.76
- Enterprise Value Revenue 17.39
- Enterprise Value EBITDA 68.87
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.70
- Next Year EPS Estimate -$2.84
- Next Quarter EPS Estimate -$0.60
- Profit Margin -57%
- Operating Margin -62%
- Return on Assets -7%
- Return on Equity -12%
- Revenue 122.69 million
- Earnings Per Share $0.61
- Revenue Per Share $2.15
- Gross Profit -47108000
- Quarterly Earnings Growth 1090.4%
View More
Highlights
- Market Capitalization 2.69 billion
- EBITDA 27.51 million
- PE Ratio -9.19
- Analyst Target Price $54.33
- Book Value Per Share $9.89
View More
Share Statistics
- Shares Outstanding 57.95 million
- Shares Float 52.79 million
- % Held by Insiders 202%
- % Held by Institutions 104.31%
- Shares Short 3.03 million
- Shares Short Prior Month 2.99 million
- Short Ratio 14.13
- Short % of Float 11%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 0.79
- 52 Week High $55.33
- 52 Week Low $26.46
- 50 Day Moving Average 48.25
- 200 Day Moving Average 43.33
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Xencor, Inc (XNCR) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Xencor, Inc (XNCR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $41.85 million | -$0.24 | -$0.36 | 32.72% |
| 2020-09-30 | 2020-11-06 | $35.37 million | -$0.22 | -$0.10 | -120% |
| 2020-06-30 | 2020-08-04 | $13.09 million | -$0.61 | -$0.54 | -13.49% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.14 | -$0.39 | 64.27% |
| 2019-12-31 | 2020-02-24 | $3.52 million | -$0.47 | -$0.43 | -8.75% |
| 2019-09-30 | 2019-11-05 | $21.76 million | -$0.18 | -$0.55 | 67% |
| 2019-06-30 | 2019-08-06 | $19.49 million | -$0.28 | -$0.45 | 37.5% |
| 2019-03-31 | 2019-05-09 | $111.94 million | $1.38 | -$0.41 | 434.22% |
| 2018-12-31 | 2019-02-25 | $11.56 million | -$0.32 | -$0.55 | 41.39% |
| 2018-09-30 | 2018-11-05 | $29.04 million | $0.05 | -$0.52 | 109.54% |
| 2018-06-30 | 2018-08-06 | $N/A | -$0.46 | -$0.48 | 4.82% |
| 2018-03-31 | 2018-05-07 | $N/A | -$0.62 | -$0.46 | -36.26% |
| 2017-12-31 | 2018-02-27 | $10.94 million | -$0.25 | -$0.35 | 28.92% |
| 2017-09-30 | 2017-11-07 | $7.09 million | -$0.33 | -$0.33 | 1.2% |
| 2017-06-30 | 2017-08-07 | $12.5 million | -$0.15 | -$0.25 | 40.94% |
| 2017-03-31 | 2017-05-09 | $4.34 million | -$0.31 | -$0.24 | -30.25% |
| 2016-12-31 | 2017-02-28 | $6.44 million | -$0.21 | -$0.31 | 32.26% |
| 2016-09-30 | 2016-11-02 | $7.82 million | -$0.20 | -$0.29 | 31.03% |
| 2016-06-30 | 2016-08-02 | $66.01 million | $1.13 | -$0.21 | 638.1% |
| 2016-03-31 | 2016-05-02 | $7.25 million | -$0.16 | -$0.27 | 41.28% |
| 2015-12-31 | 2016-03-07 | $21.75 million | $0.19 | -$0.30 | 162.81% |
| 2015-09-30 | 2015-11-03 | $3.5 million | -$0.25 | -$0.17 | -47.06% |
| 2015-06-30 | 2015-08-04 | $1.01 million | -$0.22 | -$0.18 | -22.22% |
| 2015-03-31 | 2015-05-04 | $1.49 million | -$0.19 | -$0.17 | -11.76% |
| 2014-12-31 | 2015-02-19 | $5.66 million | -$0.04 | -$0.18 | 77.78% |
| 2014-09-30 | 2014-11-10 | $848000 | -$0.20 | -$0.19 | -5.26% |
| 2014-06-30 | 2014-07-31 | $824000 | -$0.16 | -$0.19 | 15.79% |
| 2014-03-31 | 2014-05-14 | $2.18 million | -$0.12 | -$0.16 | 25% |
| 2013-12-31 | 2014-03-19 | $1.74 million | -$0.24 | -$0.14 | -71.43% |
Xencor, Inc (XNCR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Xencor, Inc (XNCR) Chart:
Xencor, Inc (XNCR) News:
Below you will find a list of latest news for Xencor, Inc (XNCR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Xencor, Inc (XNCR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 1158.96 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 269.79 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 204.37 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | CALL | 0 | 0 | 143.65 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | CALL | 0 | 0 | 86.17 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 63.57 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 6 | CALL | 0 | 5 | 117.32 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 3.7 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 3 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 1.75 | CALL | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0.25 | CALL | 0 | 40 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 52.95 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 1.6 | PUT | 0 | 12 | 66.77 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 2.05 | PUT | 0 | 1 | 165.56 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 4.6 | PUT | 0 | 10 | 194.98 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 0 | PUT | 0 | 0 | 116.65 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 0 | PUT | 0 | 0 | 135.09 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 1059.97 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 502.15 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 340.82 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 264.87 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | CALL | 0 | 0 | 198.46 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | CALL | 0 | 0 | 44.24 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | CALL | 0 | 0 | 71.37 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | CALL | 0 | 0 | 103.26 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 61.5 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | PUT | 0 | 0 | 125.08 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 148.55 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 179.97 | TRUE | 0 | 0 |
| 2024-06-21 | 35 | 0 | PUT | 0 | 0 | 204.25 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | CALL | 0 | 0 | 207.74 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 137.55 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 90.54 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 0 | CALL | 0 | 0 | 71.64 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | CALL | 0 | 0 | 68.55 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 4.9 | CALL | 1 | 0 | 72.59 | TRUE | 4.9 | 0 |
| 2024-08-16 | 17.5 | 0 | CALL | 0 | 0 | 60.06 | TRUE | 0 | 0 |
| 2024-08-16 | 20 | 2.5 | CALL | 0 | 10 | 77.67 | FALSE | 0 | 0 |
| 2024-08-16 | 22.5 | 1.25 | CALL | 0 | 3 | 91.06 | FALSE | 0 | 0 |
| 2024-08-16 | 25 | 1.6 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 30 | 0.8 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 0.6 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 3 | PUT | 0 | 1 | 54.03 | FALSE | 0 | 0 |
| 2024-08-16 | 20 | 1.6 | PUT | 0 | 4 | 47.2 | TRUE | 0 | 0 |
| 2024-08-16 | 22.5 | 0 | PUT | 0 | 0 | 55.45 | TRUE | 0 | 0 |
| 2024-08-16 | 25 | 3.3 | PUT | 0 | 1 | 48.9 | TRUE | 0 | 0 |
| 2024-08-16 | 30 | 0 | PUT | 0 | 0 | 65.21 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 0 | PUT | 0 | 0 | 139.44 | TRUE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | CALL | 0 | 0 | 56.12 | TRUE | 0 | 0 |
| 2024-11-15 | 15 | 0 | CALL | 0 | 0 | 45.21 | TRUE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | CALL | 0 | 0 | 45.78 | TRUE | 0 | 0 |
| 2024-11-15 | 20 | 0 | CALL | 0 | 0 | 57.58 | FALSE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | CALL | 0 | 0 | 72.4 | FALSE | 0 | 0 |
| 2024-11-15 | 25 | 1.3 | CALL | 0 | 1 | 77.45 | FALSE | 0 | 0 |
| 2024-11-15 | 30 | 1.3 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 15 | 0 | PUT | 0 | 0 | 46.35 | FALSE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | PUT | 0 | 0 | 56.38 | FALSE | 0 | 0 |
| 2024-11-15 | 20 | 1.75 | PUT | 0 | 11 | 42.24 | TRUE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | PUT | 0 | 0 | 51.43 | TRUE | 0 | 0 |
| 2024-11-15 | 25 | 0 | PUT | 0 | 0 | 46.08 | TRUE | 0 | 0 |
| 2024-11-15 | 30 | 0 | PUT | 0 | 0 | 53.88 | TRUE | 0 | 0 |
Latest XNCR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 24 | $19.69 |
| Jun 13, 2022 7:59 PM EST | 1 | $19.76 |
| Jun 13, 2022 7:59 PM EST | 100 | $19.76 |
| Jun 13, 2022 7:59 PM EST | 100 | $19.76 |
| Jun 13, 2022 7:59 PM EST | 100 | $19.76 |
Xencor, Inc (XNCR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039323/0001209191-20-039323-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000008025519002653/0000080255-19-002653-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000008025520001256/0000080255-20-001256-index.htm |
| 2020-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000008025520001545/0000080255-20-001545-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000021545719005670/0000215457-19-005670-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000031506619001419/0000315066-19-001419-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000031506620001290/0000315066-20-001290-index.htm |
| 2019-08-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000083423719000057/0000834237-19-000057-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000083423720002711/0000834237-20-002711-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000093247119005926/0000932471-19-005926-index.htm |
| 2020-06-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000093583620000340/0000935836-20-000340-index.htm |
| 2018-03-19 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1326732/000104746918001837/0001047469-18-001837-index.htm |
| 2018-03-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326732/000104746918001839/0001047469-18-001839-index.htm |
| 2018-03-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326732/000104746918001955/0001047469-18-001955-index.htm |
| 2018-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918019320/0001104659-18-019320-index.htm |
| 2018-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918030900/0001104659-18-030900-index.htm |
| 2018-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918042788/0001104659-18-042788-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918049170/0001104659-18-049170-index.htm |
| 2018-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918049802/0001104659-18-049802-index.htm |
| 2018-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918065971/0001104659-18-065971-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465918066849/0001104659-18-066849-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465919005721/0001104659-19-005721-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465919006766/0001104659-19-006766-index.htm |
| 2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465919008519/0001104659-19-008519-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465919010345/0001104659-19-010345-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000110465919013521/0001104659-19-013521-index.htm |
| 2019-12-27 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465919076415/0001104659-19-076415-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920017754/0001104659-20-017754-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920019055/0001104659-20-019055-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920021049/0001104659-20-021049-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920021835/0001104659-20-021835-index.htm |
| 2020-04-08 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920044671/0001104659-20-044671-index.htm |
| 2020-05-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920055442/0001104659-20-055442-index.htm |
| 2020-05-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920060029/0001104659-20-060029-index.htm |
| 2020-05-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920064236/0001104659-20-064236-index.htm |
| 2020-06-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920069455/0001104659-20-069455-index.htm |
| 2020-06-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920070154/0001104659-20-070154-index.htm |
| 2020-06-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326732/000110465920071997/0001104659-20-071997-index.htm |
| 2020-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920082667/0001104659-20-082667-index.htm |
| 2020-09-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920103036/0001104659-20-103036-index.htm |
| 2020-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000110465920103826/0001104659-20-103826-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326732/000114420419008064/0001144204-19-008064-index.htm |
| 2018-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911018008826/0001179110-18-008826-index.htm |
| 2018-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009648/0001179110-18-009648-index.htm |
| 2018-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009739/0001179110-18-009739-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911018011490/0001179110-18-011490-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004050/0001179110-19-004050-index.htm |
| 2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004286/0001179110-19-004286-index.htm |
| 2019-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019005598/0001179110-19-005598-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019007384/0001179110-19-007384-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019012669/0001179110-19-012669-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911019013159/0001179110-19-013159-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911020000425/0001179110-20-000425-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004078/0001179110-20-004078-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004802/0001179110-20-004802-index.htm |
| 2018-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118020373/0001209191-18-020373-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118032123/0001209191-18-032123-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038128/0001209191-18-038128-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038211/0001209191-18-038211-index.htm |
| 2018-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118039697/0001209191-18-039697-index.htm |
| 2018-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118039698/0001209191-18-039698-index.htm |
| 2018-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118039699/0001209191-18-039699-index.htm |
| 2018-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118039700/0001209191-18-039700-index.htm |
| 2018-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118039701/0001209191-18-039701-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046308/0001209191-18-046308-index.htm |
| 2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047522/0001209191-18-047522-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118051472/0001209191-18-051472-index.htm |
| 2018-11-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118057943/0001209191-18-057943-index.htm |
| 2018-11-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919118057952/0001209191-18-057952-index.htm |
| 2019-02-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119008770/0001209191-19-008770-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119010194/0001209191-19-010194-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119010211/0001209191-19-010211-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119010217/0001209191-19-010217-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119010222/0001209191-19-010222-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039379/0001209191-19-039379-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039380/0001209191-19-039380-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039381/0001209191-19-039381-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039383/0001209191-19-039383-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039385/0001209191-19-039385-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119039386/0001209191-19-039386-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119046981/0001209191-19-046981-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119047188/0001209191-19-047188-index.htm |
| 2019-09-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119048801/0001209191-19-048801-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119049076/0001209191-19-049076-index.htm |
| 2019-12-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119061080/0001209191-19-061080-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119061083/0001209191-19-061083-index.htm |
| 2019-12-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119061523/0001209191-19-061523-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919119061608/0001209191-19-061608-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120007734/0001209191-20-007734-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016053/0001209191-20-016053-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016057/0001209191-20-016057-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016063/0001209191-20-016063-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016071/0001209191-20-016071-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120037147/0001209191-20-037147-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039288/0001209191-20-039288-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039290/0001209191-20-039290-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039304/0001209191-20-039304-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039312/0001209191-20-039312-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039313/0001209191-20-039313-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039318/0001209191-20-039318-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326732/000120919120039323/0001209191-20-039323-index.htm |
| 2018-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1326732/000155837018003416/0001558370-18-003416-index.htm |
| 2018-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1326732/000155837018003420/0001558370-18-003420-index.htm |
| 2018-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837018004166/0001558370-18-004166-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837018006482/0001558370-18-006482-index.htm |
| 2018-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837018008506/0001558370-18-008506-index.htm |
| 2019-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1326732/000155837019001049/0001558370-19-001049-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1326732/000155837019003579/0001558370-19-003579-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1326732/000155837019003583/0001558370-19-003583-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019004661/0001558370-19-004661-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837019004727/0001558370-19-004727-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019005928/0001558370-19-005928-index.htm |
| 2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019005963/0001558370-19-005963-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019007241/0001558370-19-007241-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837019007346/0001558370-19-007346-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019009980/0001558370-19-009980-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837019009999/0001558370-19-009999-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837019011651/0001558370-19-011651-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020001232/0001558370-20-001232-index.htm |
| 2020-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1326732/000155837020001256/0001558370-20-001256-index.htm |
| 2020-02-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1326732/000155837020001260/0001558370-20-001260-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1326732/000155837020004656/0001558370-20-004656-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1326732/000155837020004662/0001558370-20-004662-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020005683/0001558370-20-005683-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837020005803/0001558370-20-005803-index.htm |
| 2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020007794/0001558370-20-007794-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020009131/0001558370-20-009131-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837020009191/0001558370-20-009191-index.htm |
| 2020-10-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020011478/0001558370-20-011478-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326732/000155837020012830/0001558370-20-012830-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326732/000155837020012969/0001558370-20-012969-index.htm |
| 2018-10-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1326732/999999999718008806/9999999997-18-008806-index.htm |
| 2019-07-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1326732/999999999719006215/9999999997-19-006215-index.htm |
| 2019-07-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1326732/999999999719006217/9999999997-19-006217-index.htm |
| 2019-07-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1326732/999999999719006218/9999999997-19-006218-index.htm |
| 2019-09-17 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1326732/999999999719006842/9999999997-19-006842-index.htm |
| 2019-09-27 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1326732/999999999720001377/9999999997-20-001377-index.htm |
Xencor, Inc (XNCR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xencor, Inc (XNCR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 202%Institutional Ownership: 10431%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-03-15 | Edgardo Jr Baracchini | Chief Business Officer | Sell | 40,000.00 | 30.89 | 1,235,744.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118020373/0001209191-18-020373-index.htm |
| 2018-08-09 | John R Desjarlais | Sr. V.P., Research & CSO | Sell | 20,133.00 | 40.61 | 817,629.32 | 102,965.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046308/0001209191-18-046308-index.htm |
| 2019-08-21 | John J Kuch | Sr. Vice President & CFO | Buy | 20,000.00 | 11.05 | 221,000.00 | 113,629.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919119047188/0001209191-19-047188-index.htm |
| 2020-04-06 | JOHN S III STAFFORD | 10% Share Holder | Sell | 44,771.00 | 31.84 | 1,425,508.64 | 1,206,005.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004802/0001179110-20-004802-index.htm |
| 2018-08-09 | John R Desjarlais | Sr. V.P., Research & CSO | Buy | 35,000.00 | 4.25 | 148,750.00 | 123,098.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046308/0001209191-18-046308-index.htm |
| 2020-01-08 | JOHN S III STAFFORD | 10% Share Holder | Sell | 60,876.00 | 36.68 | 2,232,931.68 | 1,250,776.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020000425/0001179110-20-000425-index.htm |
| 2018-08-13 | Edgardo Jr Baracchini | Chief Business Officer | Buy | 12,734.00 | 11.05 | 140,710.70 | 12,941.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2020-01-07 | JOHN S III STAFFORD | 10% Share Holder | Sell | 6,047.00 | 35.95 | 217,389.65 | 1,311,652.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020000425/0001179110-20-000425-index.htm |
| 2020-01-06 | JOHN S III STAFFORD | 10% Share Holder | Sell | 58,862.00 | 35.81 | 2,107,907.08 | 1,317,699.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020000425/0001179110-20-000425-index.htm |
| 2019-12-26 | JOHN S III STAFFORD | 10% Share Holder | Sell | 4,119.00 | 40.04 | 164,924.76 | 1,376,561.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019013159/0001179110-19-013159-index.htm |
| 2019-12-24 | JOHN S III STAFFORD | 10% Share Holder | Sell | 43,720.00 | 39.71 | 1,736,121.20 | 1,380,680.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019013159/0001179110-19-013159-index.htm |
| 2019-12-23 | JOHN S III STAFFORD | 10% Share Holder | Sell | 91,677.00 | 39.51 | 3,622,341.62 | 1,424,400.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019013159/0001179110-19-013159-index.htm |
| 2020-03-02 | Bassil I Dahiyat | President and CEO | Buy | 23,605.00 | 143,504.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016053/0001209191-20-016053-index.htm | ||
| 2019-12-20 | JOHN S III STAFFORD | 10% Share Holder | Sell | 73,423.00 | 39.39 | 2,892,131.97 | 1,516,077.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019013159/0001179110-19-013159-index.htm |
| 2019-12-11 | JOHN S III STAFFORD | 10% Share Holder | Sell | 37,951.00 | 38.68 | 1,467,944.68 | 1,589,500.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019012669/0001179110-19-012669-index.htm |
| 2019-12-10 | JOHN S III STAFFORD | 10% Share Holder | Sell | 252,225.00 | 40.13 | 10,121,789.25 | 1,627,451.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019012669/0001179110-19-012669-index.htm |
| 2019-12-09 | JOHN S III STAFFORD | 10% Share Holder | Sell | 120,324.00 | 41.64 | 5,009,749.90 | 1,879,676.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019012669/0001179110-19-012669-index.htm |
| 2018-08-14 | Paul A Foster | Chief Medical Officer | Buy | 15,496.00 | 11.05 | 171,230.80 | 20,448.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-10 | Edgardo Jr Baracchini | Chief Business Officer | Sell | 28,983.00 | 40.03 | 1,160,044.58 | 207.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2018-08-13 | Edgardo Jr Baracchini | Chief Business Officer | Sell | 12,734.00 | 40.35 | 513,874.20 | 207.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2018-08-16 | Paul A Foster | Chief Medical Officer | Buy | 20,739.00 | 11.05 | 229,165.95 | 25,691.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-09 | Edgardo Jr Baracchini | Chief Business Officer | Sell | 8,283.00 | 40.35 | 334,198.34 | 29,190.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2018-06-15 | Bassil I Dahiyat | President and CEO | Sell | 50,000.00 | 40.51 | 2,025,690.00 | 293,067.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038211/0001209191-18-038211-index.htm |
| 2020-03-02 | Celia Eckert | VP, General Counsel and Secy | Buy | 3,147.00 | 3,147.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016071/0001209191-20-016071-index.htm | ||
| 2019-12-16 | Allen Yang | SVP, Chief Medical Officer | Buy | 31,900.00 | 31,900.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919119061083/0001209191-19-061083-index.htm | ||
| 2018-06-15 | Bassil I Dahiyat | President and CEO | Buy | 50,000.00 | 4.25 | 212,500.00 | 343,067.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038211/0001209191-18-038211-index.htm |
| 2018-08-09 | Edgardo Jr Baracchini | Chief Business Officer | Buy | 37,266.00 | 11.05 | 411,789.30 | 37,473.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046514/0001209191-18-046514-index.htm |
| 2018-03-15 | Edgardo Jr Baracchini | Chief Business Officer | Buy | 40,000.00 | 0.59 | 23,600.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118020373/0001209191-18-020373-index.htm |
| 2018-09-17 | Paul A Foster | Chief Medical Officer | Buy | 40,000.00 | 11.05 | 442,000.00 | 44,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118051472/0001209191-18-051472-index.htm |
| 2018-08-14 | Paul A Foster | Chief Medical Officer | Sell | 15,496.00 | 41.11 | 636,980.13 | 4,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-15 | Paul A Foster | Chief Medical Officer | Sell | 106.00 | 41.10 | 4,356.60 | 4,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-16 | Paul A Foster | Chief Medical Officer | Sell | 20,739.00 | 41.10 | 852,372.90 | 4,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2018-08-17 | Paul A Foster | Chief Medical Officer | Sell | 3,659.00 | 40.10 | 146,725.90 | 4,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047522/0001209191-18-047522-index.htm |
| 2018-09-17 | Paul A Foster | Chief Medical Officer | Sell | 40,000.00 | 46.03 | 1,841,208.00 | 4,952.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118051472/0001209191-18-051472-index.htm |
| 2020-03-20 | Ronin Capital, LLC | 10% Share Holder | Sell | 50,770.00 | 29.89 | 1,517,642.23 | 5,012,430.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004078/0001179110-20-004078-index.htm |
| 2018-09-14 | JOHN S III STAFFORD | 10% Share Holder | Sell | 1,000.00 | 48.05 | 48,054.00 | 5,017,848.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018011490/0001179110-18-011490-index.htm |
| 2018-07-17 | JOHN S III STAFFORD | 10% Share Holder | Sell | 36,500.00 | 41.24 | 1,505,260.00 | 5,018,848.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009739/0001179110-18-009739-index.htm |
| 2018-07-16 | JOHN S III STAFFORD | 10% Share Holder | Sell | 26,888.00 | 40.67 | 1,093,534.96 | 5,055,348.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009739/0001179110-18-009739-index.htm |
| 2019-03-15 | JOHN S III STAFFORD | 10% Share Holder | Buy | 38,300.00 | 29.02 | 1,111,466.00 | 5,056,148.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004050/0001179110-19-004050-index.htm |
| 2019-03-18 | JOHN S III STAFFORD | 10% Share Holder | Buy | 1,100.00 | 29.90 | 32,890.00 | 5,057,248.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004050/0001179110-19-004050-index.htm |
| 2018-08-15 | Paul A Foster | Chief Medical Officer | Buy | 106.00 | 11.05 | 1,171.30 | 5,058.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047214/0001209191-18-047214-index.htm |
| 2019-03-22 | JOHN S III STAFFORD | 10% Share Holder | Buy | 2,000.00 | 29.96 | 59,920.00 | 5,059,248.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004286/0001179110-19-004286-index.htm |
| 2019-03-25 | JOHN S III STAFFORD | 10% Share Holder | Buy | 3,500.00 | 29.77 | 104,195.00 | 5,062,748.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019004286/0001179110-19-004286-index.htm |
| 2020-03-19 | Ronin Capital, LLC | 10% Share Holder | Sell | 26,800.00 | 28.23 | 756,593.48 | 5,063,200.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004078/0001179110-20-004078-index.htm |
| 2019-05-02 | JOHN S III STAFFORD | 10% Share Holder | Buy | 14,611.00 | 29.87 | 436,407.19 | 5,077,359.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019005598/0001179110-19-005598-index.htm |
| 2018-07-13 | JOHN S III STAFFORD | 10% Share Holder | Sell | 48,312.00 | 41.97 | 2,027,683.63 | 5,082,236.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009739/0001179110-18-009739-index.htm |
| 2019-06-06 | JOHN S III STAFFORD | 10% Share Holder | Buy | 12,641.00 | 29.87 | 377,586.67 | 5,090,000.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911019007384/0001179110-19-007384-index.htm |
| 2018-07-12 | JOHN S III STAFFORD | 10% Share Holder | Sell | 58,000.00 | 39.55 | 2,293,900.00 | 5,130,548.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009648/0001179110-18-009648-index.htm |
| 2018-07-11 | JOHN S III STAFFORD | 10% Share Holder | Sell | 30,007.00 | 39.63 | 1,189,177.41 | 5,188,548.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009648/0001179110-18-009648-index.htm |
| 2018-07-10 | JOHN S III STAFFORD | 10% Share Holder | Sell | 50,293.00 | 39.89 | 2,006,187.77 | 5,218,555.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018009648/0001179110-18-009648-index.htm |
| 2018-06-20 | JOHN S III STAFFORD | 10% Share Holder | Sell | 92,779.00 | 40.05 | 3,715,798.95 | 5,261,348.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018008826/0001179110-18-008826-index.htm |
| 2018-06-19 | JOHN S III STAFFORD | 10% Share Holder | Sell | 103,454.00 | 39.77 | 4,114,365.58 | 5,354,127.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018008826/0001179110-18-008826-index.htm |
| 2018-06-18 | JOHN S III STAFFORD | 10% Share Holder | Sell | 53,767.00 | 39.88 | 2,144,227.96 | 5,457,581.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911018008826/0001179110-18-008826-index.htm |
| 2019-08-19 | John R Desjarlais | Sr. V.P., Research & CSO | Sell | 35,000.00 | 40.69 | 1,424,150.00 | 56,346.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919119046981/0001209191-19-046981-index.htm |
| 2018-06-13 | John J Kuch | Sr. Vice President & CFO | Sell | 25,000.00 | 41.64 | 1,040,945.00 | 56,629.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038128/0001209191-18-038128-index.htm |
| 2020-04-06 | JOHN S III STAFFORD | 10% Share Holder | Sell | 600,000.00 | 27.10 | 16,260,000.00 | 606,005.00 | https://www.sec.gov/Archives/edgar/data/1326732/000117911020004802/0001179110-20-004802-index.htm |
| 2019-08-21 | John J Kuch | Sr. Vice President & CFO | Sell | 40,000.00 | 41.27 | 1,650,724.00 | 73,629.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919119047188/0001209191-19-047188-index.htm |
| 2020-03-02 | John J Kuch | Sr. Vice President & CFO | Buy | 6,777.00 | 80,422.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016063/0001209191-20-016063-index.htm | ||
| 2019-09-06 | John R Desjarlais | Sr. V.P., Research & CSO | Buy | 27,522.00 | 4.25 | 116,968.50 | 83,868.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919119049076/0001209191-19-049076-index.htm |
| 2018-08-17 | Paul A Foster | Chief Medical Officer | Buy | 3,659.00 | 11.05 | 40,431.95 | 8,611.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118047522/0001209191-18-047522-index.htm |
| 2018-08-10 | John R Desjarlais | Sr. V.P., Research & CSO | Sell | 14,867.00 | 40.03 | 595,091.82 | 88,098.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118046308/0001209191-18-046308-index.htm |
| 2020-06-12 | John J Kuch | Sr. Vice President & CFO | Buy | 10,000.00 | 11.05 | 110,500.00 | 90,602.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919120037147/0001209191-20-037147-index.htm |
| 2018-06-13 | John J Kuch | Sr. Vice President & CFO | Buy | 35,853.00 | 4.25 | 152,375.25 | 92,482.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919118038128/0001209191-18-038128-index.htm |
| 2020-03-02 | John R Desjarlais | Sr. V.P., Research & CSO | Buy | 9,085.00 | 92,953.00 | https://www.sec.gov/Archives/edgar/data/1326732/000120919120016057/0001209191-20-016057-index.htm |